Stylianos Michalakis is Professor for Ocular Gene Therapy at the Eye Hospital of the LMU Hospital. His group focuses on improving AAV vector technologies and developing and translating AAV-based gene therapies for ophthalmic diseases. He is named as inventor in 7 pending or active AAV vector patents and is a scientific co-founder of the LMU gene therapy start-up ViGeneron GmbH.